Carrier screening for cystic fibrosis: Test acceptance and one year follow-up

American Journal of Medical Genetics

Volumn 73, Issue 4, 1997, Pages 378-386

  Levenkron, Jeffrey C ^a   Loader, Starlene ^a   Rowley, Peter T ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Carrier screening; Cystic fibrosis; Genetic screening; Population screening; Prenatal diagnosis; Prenatal screening

Indexed keywords

ABORTION; ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EMPIRICAL APPROACH; GENETICS AND REPRODUCTION;

ABORTION, INDUCED; ANXIETY; ATTITUDE TO HEALTH; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HETEROZYGOTE; HUMANS; PATIENT EDUCATION; PREGNANCY; PRENATAL DIAGNOSIS; PRIMARY HEALTH CARE; REPRODUCTION;

EID: 0030781298     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19971231)73:4<378::AID-AJMG2>3.0.CO;2-K     Document Type: Article

References (38)

1. Adams MM, Bruce FC, Shulman HB, Kendrick JS, Brogan DJ, PRAMS Working Group (1993): Pregnancy planning and pre-conception counseling. Obstet Gynecol 82:955-959.
2. Asch DA, Patton JP, Hershey JC, Mennuti MT (1993): Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol 168:1-6.
3. Beaudet AL (1990): Carrier screening for cystic fibrosis. Am J Hum Genet 47:603-605.
4. Bekker H., Denniss G, Modell M, Bobrow M, Marteau T (1994): The impact of population based screening for carriers of cystic fibrosis. J Med Genet 31:364-368.
5. Biesecker L, Bowles-Biesecker B, Collins F, Kaback M, Wilfond B (1992): General population screening for cystic fibrosis is premature. Am J Hum Genet 50:438-439.
6. Botkin JR, Alemagno S (1992): Carrier screening for cystic fibrosis: A pilot study of the attitudes of pregnant women. Am J Pub Health 82:723-725.
7. Brock DJ (1995): Heterozygote screening for cystic fibrosis. Eur J Hum Genet 3:2-13.
8. Decruyenaere M, Evers-Kiebooms G, Denayer L, Van den Berghe H (1992): Cystic fibrosis: Community knowledge and attitudes towards carrier screening and prenatal diagnosis. Clin Genet 41:189-196.
9. Doherty RA, Palomaki GE, Kloza, EM, Erickson JL, Dostal DA, Haddow JE (1994): Prenatal screening for cystic fibrosis. Lancet 343:172.
10. Faden RR, Tambor ES, Chase GA, Geller G, Hofman KJ, Holtzman NA (1994): Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening. Am J Med Genet 50:1-11.
11. Farrell PM, Mischler EH (1992): Newborn screening for cystic fibrosis. Adv Pediatr 39:31-64.
12. FitzSimmons SC (1993): The changing epidemiology of cystic fibrosis. J Pediatr 122:1-9.
13. Gilbert F (1990): Is population screening for cystic fibrosis appropriate now? Am J Hum Genet 46:394-395.
14. Kaplan F, Clow C, Scriver CR (1991): Cystic fibrosis carrier screening by DNA analysis: A pilot study of attitudes among participants. Am J Hum Genet 49:240-242.
15. Kerem E, Lynch A (1991): Screening for cystic fibrosis: ethical and social issues. Am Rev Resp Dis 143:457-460.
16. Livingstone J, Axton RA, Gilfillan A, Mennie A, Compton M, Liston WA, Calder AA, Gordon AI, Brock DI (1994): Antenatal screening for cystic fibrosis: A trial of the couple model. Br Med J 308:1459-1462.
17. Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH, Jr, Rowley PT (1996): Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet 59:234-247.
18. Miedzybrodzka Z, Semper J, Shackley P, Abdulla M, Donaldson C (1995a): Stepwise or couple antenatal carrier screening for cystic fibrosis?: Women's preferences and willingness to pay. J Med Genet 32:282-283.
19. Miedzybrodzka ZH, Hall MH, Mollison J, Templeton A, Russell IT, Dean JC, Kelly KF, Marteau TM, Haites NE (1995b): Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. Br Med J 310:353-357.
20. Miller SM (1987): Monitoring and blunting: Validation of a questionnaire to assess styles of information seeking under threat. J Personal Soc Psychol 52:345-353.
21. National Institutes of Health Consensus Development Conferences Statement: Genetic Testing for Cystic Fibrosis, April 14-16, 1997.
22. Riordan JR, Rommens J, Kerem B, Alon N, Rozmahel R, Grzekzak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC (1989): Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073.
23. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, Collins FS (1989): Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 245:1059-1065.
24. Rosenstock IM (1990): The health belief model: Explaining health behavior through expectancies. In Glanz K, Lewis FM, Rimer BK (eds): "Health Behavior and Health Education." San Francisco: Jossey-Bass, pp 39-62.
25. Rowley PT, Loader S, Levenkron JC, Phelps CE (1993): Cystic fibrosis carrier screening: Knowledge and attitudes of prenatal care providers. Am J Prev Med 9:261-266.
26. Scriver CR, Fujiwara TM (1992): Cystic fibrosis genotypes and views on screening are both heterogeneous and population related. Am J Hum Genet 51:943-950.
27. Spielberger CD, Gorsuch RL, Lushene RE (1979): The state-trait anxiety inventory. Short form. University of South Florida.
28. Unpublished, and (1983): Manual for Y Form. Palo Alto, CA: Consulting Psychologists Press.
29. Tambor ES, Bernhardt BA, Chase GA, Faden RR, Geller G, Hofman KJ, Holtzman NA (1994): Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization. Am J Hum Genet 55:626-637.
30. Tsui L-C (1996): CF Genetic Analysis Consortium Newsletter 67, January 5.
31. US Congress, Office of Technology Assessment (1992): Cystic fibrosis and DNA tests: Implications of carrier screening, OTA-BA-532. Washington, DC: U.S. Government Printing office.
32. Wald NJ (1991): Couple screening for cystic fibrosis. Lancet 338:1318-1319.
33. Wall J, Cai S, Chehab FF (1995): A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat 5:333-8.
34. Watson EK, Williamson R, Chapple J (1991): Attitudes to carrier screening for cystic fibrosis: A survey of health care professionals, relatives of sufferers, and other members of the public. Br J Gen Pract 41:237-240.
35. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL (1995): Cystic fibrosis. In CR. Scriver, AL Beaudet, WS Sly, D Valle (eds): "The Metabolic and Molecular Bases of Inherited Disease." New York: McGraw-Hill, p 3799.
36. Wertz DC, James SR, Rosenfield JM, Esbe RW (1992): Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families. Am J Hum Genet 50:1077-1085.
37. Wilfond BS, Fost N (1990): The cystic fibrosis gene: Medical and social implications for heterozygote detection. JAMA 263:2777-2783.
38. Wilfond BS, Nolan K (1993): National policy development for the clinical application of genetic diagnostic technologies: Lessons from cystic fibrosis. JAMA 270:2948-2954.